Blockade of both L-selectin and α4 integrins abrogates naive CD4 cell trafficking and responses in gut-associated lymphoid organs

被引:17
作者
Bradley, LM
Malo, ME
Fong, S
Tonkonogy, SL
Watson, SR
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Genentech Inc, Dept Immunol, S San Francisco, CA 94080 USA
[3] N Carolina State Univ, Coll Vet Med, Dept Microbiol Pathol & Parasitol, Raleigh, NC 27606 USA
[4] Eos Biosyst, S San Francisco, CA 94080 USA
关键词
adhesion molecules; CD4 T lymphocytes; homing; recirculation;
D O I
10.1093/intimm/10.7.961
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The recirculation of naive lymphocytes from blood to lymph that is initiated in high endothelial venules (HEV) of secondary lymphoid organs such as lymph nodes and Peyer's patches (PP) is regulated by multiple interactions of adhesion receptor/counter-receptor pairs involving both selectins and integrins. We showed previously that blocking of only L-selectin is sufficient to ablate trafficking of naive CD4 cells and the development of their responses in peripheral lymph nodes but not in PP where alpha(4)beta(7) integrins are thought to primarily regulate entry. However, although antibody to alpha(4) integrins partially inhibited homing of naive CD4 cells to PP and not to lymph nodes, there was no effect on the development primary responses in these tissues or spleens. Since previous studies indicate that both alpha(4)beta(7) integrins and L-selectin regulate adhesion of naive cells to PP HEV, we examined the effect a blockade of bath adhesion pathways on the recirculation of naive CD4 cells. There was no detectable homing of naive CD4 cells to PP or lymph nodes when interactions with both receptors were inhibited, resulting in a profound depletion of naive CD4 cells and loss of antigen responses in these sites. In contrast, increased numbers of naive CD4 cells and responses of higher magnitude were found in the spleen. The results demonstrate recirculation of naive CD4 cells through tissues where entry is controlled through HEV is essential for the local generation of primary responses.
引用
收藏
页码:961 / 968
页数:8
相关论文
共 39 条
[1]   THE INTEGRIN VLA-4 SUPPORTS TETHERING AND ROLLING IN FLOW ON VCAM-1 [J].
ALON, R ;
KASSNER, PD ;
CARR, MW ;
FINGER, EB ;
HEMLER, ME ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1995, 128 (06) :1243-1253
[2]   LYMPHOCYTE HOMING AND LEUKOCYTE ROLLING AND MIGRATION ARE IMPAIRED IN L-SELECTIN-DEFICIENT MICE [J].
ARBONES, ML ;
ORD, DC ;
LEY, K ;
RATECH, H ;
MAYNARDCURRY, C ;
OTTEN, G ;
CAPON, DJ ;
TEDDER, TF .
IMMUNITY, 1994, 1 (04) :247-260
[3]   RAPID G-PROTEIN-REGULATED ACTIVATION EVENT INVOLVED IN LYMPHOCYTE BINDING TO HIGH ENDOTHELIAL VENULES [J].
BARGATZE, RF ;
BUTCHER, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :367-372
[4]   DISTINCT ROLES OF L-SELECTIN AND INTEGRINS ALPHA-4-BETA-7 AND LFA-1 IN LYMPHOCYTE HOMING TO PEYERS PATCH-HEV IN-SITU - THE MULTISTEP MODEL CONFIRMED AND REFINED [J].
BARGATZE, RF ;
JUTILA, MA ;
BUTCHER, EC .
IMMUNITY, 1995, 3 (01) :99-108
[5]   L-SELECTIN-MEDIATED LYMPHOCYTE ROLLING ON MADCAM-1 [J].
BERG, EL ;
MCEVOY, LM ;
BERLIN, C ;
BARGATZE, RF ;
BUTCHER, EC .
NATURE, 1993, 366 (6456) :695-698
[6]   ALPHA-4 INTEGRINS MEDIATE LYMPHOCYTE ATTACHMENT AND ROLLING UNDER PHYSIOLOGICAL FLOW [J].
BERLIN, C ;
BARGATZE, RF ;
CAMPBELL, JJ ;
VONANDRIAN, UH ;
SZABO, MC ;
HASSLEN, SR ;
NELSON, RD ;
BERG, EL ;
ERLANDSEN, SL ;
BUTCHER, EC .
CELL, 1995, 80 (03) :413-422
[7]   ALPHA-4-BETA-7-INTEGRIN MEDIATES LYMPHOCYTE BINDING TO THE MUCOSAL VASCULAR ADDRESSIN MADCAM-1 [J].
BERLIN, C ;
BERG, EL ;
BRISKIN, MJ ;
ANDREW, DP ;
KILSHAW, PJ ;
HOLZMANN, B ;
WEISSMAN, IL ;
HAMANN, A ;
BUTCHER, EC .
CELL, 1993, 74 (01) :185-195
[8]   ENTRY OF NAIVE CD4 T-CELLS INTO PERIPHERAL LYMPH-NODES REQUIRES L-SELECTIN [J].
BRADLEY, LM ;
WATSON, SR ;
SWAIN, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2401-2406
[9]   Lymphocyte migration into tissue: The paradigm derived from CD4 subsets [J].
Bradley, LM ;
Watson, SR .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) :312-320
[10]  
BRADLEY LM, 1992, J IMMUNOL, V148, P324